Atlas Trials

Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma

Clinical trial NCT01531244 · WITHDRAWN

Trial details

NCT number
NCT01531244
Sponsor
Washington University School of Medicine
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2014-12-01
Primary completion
2016-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.